Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WATSON TO PAY $70 MIL. UP FRONT FOR HMR's RUGBY GENERIC DIVISION; HOECHST DIVESTING GENERIC DIVISIONS BEFORE NYSE LISTING SCHEDULED FOR SEPT. 24

Executive Summary

Watson Pharmaceuticals is paying $70 mil. up front to acquire the Rugby generic business from Hoechst Marion Roussel, the companies announced Aug. 26.

You may also be interested in...



Hoechst Sells Copley Stake To Teva For One-Fifth Of 1993 Purchase Price

Hoechst has completed its exit from the generic pharmaceutical industry by agreeing to sell its stake in Copley to Teva-USA for $114 mil.

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011

UsernamePublicRestriction

Register

OM008605

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel